~67 spots leftby Jun 2030

Appetite Awareness Training + Diabetes Prevention for Type 2 Diabetes

Recruiting in Palo Alto (17 mi)
RG
Overseen byRachel Goode, PhD,MPH,LCSW
Age: 18 - 65
Sex: Female
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of North Carolina, Chapel Hill
No Placebo Group

Trial Summary

What is the purpose of this trial?

Black Americans are disproportionately affected by diabetes, with nearly double the rates of type 2 diabetes mellitus (T2DM), compared to non-Hispanic White adults. Though numerous factors affect these disparities, one modifiable risk factor may be that of binge eating (BE), which increases risk for binge-eating disorder (BED), which is associated with severe obesity, and often precedes a T2DM diagnosis, beginning in childhood or adolescence. Nearly 30% of Black women with obesity report binge eating episodes. Furthermore, given that binge and overeating may disparately increase the odds of obesity in Black adults (15-fold increase vs. 6-fold increase in White adults), reducing this behavior will be critical to prevent continued disparities in T2DM diagnosis. Given that Black women have the highest rates of obesity in the nation (57%), report disparate rates of weight gain between young adulthood and mid adulthood, and report disparate rates of emotional eating in adolescence, which is a risk factor for BE, one pathway to reducing disparities in T2DM risk in Black women may be to reduce binge eating and prevent weight gain in emerging adulthood (ages 18-25).

Research Team

RG

Rachel Goode, PhD,MPH,LCSW

Principal Investigator

University of North Carolina, Chapel Hill

Eligibility Criteria

This trial is for Black emergent adults who may be at risk of developing type 2 diabetes due to factors like obesity and binge eating. Participants should have a history or current issue with binge eating but not yet diagnosed with diabetes. It's aimed at preventing the onset of type 2 diabetes by addressing modifiable behaviors.

Inclusion Criteria

Black women
I am between 18 and 25 years old.
Have access to a smartphone
See 3 more

Exclusion Criteria

I have type 2 diabetes.
Have no internet access
Currently pregnant
See 2 more

Treatment Details

Interventions

  • Appetite Awareness Training (AAT) (Behavioral Intervention)
  • Diabetes Prevention Program (DPP) (Behavioural Intervention)
Trial OverviewThe study tests Appetite Awareness Training (AAT) combined with the Diabetes Prevention Program (DPP). These interventions are designed to help participants manage their eating habits, reduce binge eating episodes, and ultimately lower their risk of developing type 2 diabetes.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Diabetes Prevention Program (DPP) onlyExperimental Treatment1 Intervention
Participants are randomized into the DPP group and will be able to access the program's content.
Group II: Appetite Awareness Training (AAT) and Diabetes Prevention Program (DPP)Experimental Treatment1 Intervention
Participants are randomized into the AAT and DPP groups and receive content from both programs for 12 months.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of North Carolina, Chapel Hill

Lead Sponsor

Trials
1,588
Recruited
4,364,000+
Dr. Peggy P. McNaull profile image

Dr. Peggy P. McNaull

University of North Carolina, Chapel Hill

Chief Medical Officer

MD from Louisiana State University School of Medicine

Dr. Lynne Fiscus profile image

Dr. Lynne Fiscus

University of North Carolina, Chapel Hill

Chief Executive Officer since 2020

MD from Georgetown University, MPH from UNC